Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-001301

Options or other derivatives

  • President, R & D acquired 1,230,948 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Amado Rafael President, R & D 2019-01-04 Grant or award · Option to purchase Ordinary Shares +1,006,224 1,006,224 D
Amado Rafael President, R & D 2019-01-04 Grant or award · Option to purchase Ordinary Shares +224,724 224,724 D
Loading xslF345X03/a4.xml…